Abstract: This invention relates to 1-benzoyl (and 1-substituted benzoyl)-3-(1,2,3,4-tetrahydro-4-oxo-1-naphthyl)ureas, novel and useful intermediates for the preparation of 1,2,3,4-tetrahydro-4-oxo-1-naphthylurea and certain derivatives thereof. The above tetrahydro-4-oxo-1-naphthyl-urea and certain derivatives thereof are animal growth promoting agents.This invention further relates to methods of preparation of said 1-benzoyl (and 1-substituted benzoyl) 3-(1,2,3,4-tetrahydro-4-oxo-1-naphthyl)ureas.
Abstract: This disclosure describes 1,2,3,4-tetrahydro-4-oxo-(oxy)-1-naphthylamine and novel derivatives thereof and methods of preparation of said compounds. These novel compounds are useful and valuable intermediates for the preparation of 1,2,3,4-tetrahydro-4-oxo(oxy)-1-naphthylurea and thiourea compounds and certain derivatives thereof which are animal growth promoters.
Abstract: This disclosure describes a novel series of potent antibacterial agents derived by reductive alkylation of antibiotic BM123.gamma. with certain classes of aldehydes and ketones.
Abstract: This disclosure describes a novel method for improving feed efficiency and accelerating the growth rate of veterinary homothermic animals by administering to said animals a growth-promoting amount of a cycloalkano[b]thien-4-ylurea or thiourea.
Abstract: This disclosure describes compounds of the 11-deoxyprostaglandin E.sub.2, F.sub.2.sub..alpha., F.sub.2.sub..beta., E.sub.3, F.sub.3.sub..alpha., and F.sub.3.sub..beta. series having bronchodilator activity.
Type:
Grant
Filed:
December 29, 1975
Date of Patent:
July 5, 1977
Inventors:
Charles Vincent Grudzinskas, Martin Joseph Weiss
Abstract: This disclosure describes compounds of the class of 5- or 6-substituted 2,3-bis(4-alkyl-1-piperazinyl)quinoxalines useful for ameliorating cecal and hepatic amebic infestations in warm-blooded animals.
Type:
Grant
Filed:
July 16, 1976
Date of Patent:
June 14, 1977
Assignee:
American Cyanamid Company
Inventors:
Paul Frank Fabio, Yang-I Lin, Stanley Albert Lang, Jr., Andrew Stephen Tomcufcik
Abstract: This disclosure describes novel 15-hydroxy-16,16-spirocycloalkyl prostanoic acids and derivatives and congeners thereof which are useful as bronchodilators and gastric acid secretion inhibitors.
Type:
Grant
Filed:
July 2, 1975
Date of Patent:
June 7, 1977
Assignee:
American Cyanamid Company
Inventors:
Robert Eugene Schaub, Martin Joseph Weiss
Abstract: This disclosure describes two new antibacterial agents designated cis-BM123.gamma..sub.1 and cis-BM123.gamma..sub.2 produced by a novel photolytic process whereby trans-BM123.gamma..sub.1 and trans-BM123.gamma..sub.2 are transformed to their corresponding cis-isomers. The new antibacterial agents are active against a variety of microorganisms and thus are useful in inhibiting the growth of such bacteria wherever they may be found.
Abstract: This disclosure describes compounds of the class of substituted 9-oxoprostanoic acids and the esters and cationic salts thereof, useful as antimicrobial agents, hypotensive agents, anti-ulcer agents, or as intermediates, and novel processes for preparing the same.
Type:
Grant
Filed:
April 3, 1972
Date of Patent:
April 19, 1977
Assignee:
American Cyanamid Company
Inventors:
Robert Eugene Schaub, Karel Francis Bernady, Martin Joseph Weiss
Abstract: This disclosure describes novel 11-deoxy-13,14-dihydro-prostaglandin-9-ketals useful as bronchodilators and as gastric acid secretion inhibitors.
Type:
Grant
Filed:
October 14, 1975
Date of Patent:
April 12, 1977
Assignee:
American Cyanamid Company
Inventors:
Robert Eugene Schaub, Middleton Brawner Floyd, Jr., Martin Joseph Weiss
Abstract: This disclosure describes compounds of the class of 1-(para-substituted-phenyl)-1H-tetrazoles which possess anti-microbial and anti-neoplastic activity.
Type:
Grant
Filed:
November 10, 1975
Date of Patent:
March 1, 1977
Assignee:
American Cyanamid Company
Inventors:
William Vincent Curran, Andrew Stephen Tomcufcik, Adma Schneller Ross
Abstract: This disclosure describes 3-triphenylmethoxy-1-alkynes, 3-triphenylmethoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates useful as intermediates for the preparation of certain 11-hydroxy- and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives which possess bronchodilator, hypotensive, and anti-ulcer activity.
Type:
Grant
Filed:
September 18, 1975
Date of Patent:
February 8, 1977
Assignee:
American Cyanamid Company
Inventors:
Karel Francis Bernady, Middleton Brawner Floyd, Jr., John Frank Poletto, Robert Eugene Schaub, Martin Joseph Weiss
Abstract: This disclosure describes 5 new antibacterial agents designated BM123.alpha., BM123.beta. .sub.1, BM123.beta..sub.2, BM123.gamma..sub.1, and BM123.gamma..sub.2 produced in a microbiological fermentation under controlled conditions using a new strain of an undetermined species of Nocardia and mutants thereof. The new antibacterial agents are active against a variety of microorganisms and thus are useful in inhibiting the growth of such bacteria wherever they may be found.
Type:
Grant
Filed:
August 21, 1975
Date of Patent:
February 8, 1977
Assignee:
American Cyanamid Company
Inventors:
John Henry Edward James Martin, Homer David Tresner, John Norman Porter
Abstract: This invention relates to ureidotetralin compounds and derivatives and selected enantiomers thereof. This invention also relates to methods for the preparation of said compounds which are useful as animal growth regulators and/or herbicidal agents.
Type:
Grant
Filed:
January 26, 1976
Date of Patent:
January 25, 1977
Assignee:
American Cyanamid Company
Inventors:
Larry Dean Spicer, Joseph Michael Pensack, Robert Daniel Wilbur, Gary Michael Demkovich
Abstract: This disclosure described homologues, analogues, congeners, and derivatives of 9-oxo-13-trans-prostenamide and of 9-hydroxy-13-trans-prostenamide, having antimicrobial activity and prostaglandin-like hypotensive activity.
Type:
Grant
Filed:
January 10, 1974
Date of Patent:
September 21, 1976
Assignee:
American Cyanamid Company
Inventors:
Karel Francis Bernady, Middleton Brawner Floyd, Jr., John Frank Poletto, Robert Eugene Schaub, Martin Joseph Weiss
Abstract: This disclosure describes 2-substituted-3,4-epoxy-cyclopentan-1-ones, 2-substituted-3,4-epoxycyclopentan-1-ols, and various 2-substituted-cyclopentenones useful as intermediates for the preparation of certain 11-hydroxy- and 11-deoxy-9-keto(or hydroxy)-prostanoic acid derivatives which possess bronchodilator, hypotensive, and anti-ulcer activity.
Type:
Grant
Filed:
August 11, 1975
Date of Patent:
June 29, 1976
Assignee:
American Cyanamid Company
Inventors:
Karel Francis Bernady, Middleton Brawner Floyd, Jr., John Frank Poletto, Robert Eugene Schaub, Martin Joseph Weiss